Biotechnology company “Qiyu Biotech” was invested by Cointreau Investment and Wosheng Capital with a series A financing worth of tens of millions of yuan

0
Biotechnology company
Biotechnology company "Qiyu Biotech" was invested by Cointreau Investment and Wosheng Capital with a series A financing worth of tens of millions of yuan

Biotechnology company “Qiyu Biotech” has completed a series A financing of tens of millions of yuan co-invested by Cointreau Investment and Wosheng Capital. This round of financing will mainly be used for preclinical development of major projects.

Qiyu Biotech focuses on the R&D of innovative macromolecular biological drugs, aiming to develop new therapeutic drugs to benefit patients in the fields of refractory cancer and autoimmune diseases in China and the world.

South Africa Today


Read more at VolaNews

Disclaimer: The views of authors published on South Africa Today are their own and do not necessarily represent the views of South Africa Today. By viewing, visiting, using, or interacting with SouthAfricaToday.net, you are agreeing to all the provisions of the Terms of Use Policy and the Privacy Policy.